CDKN1A and plasma cell myeloma: Lenalidomide provokes cell cycle arrest in cell lines that typify Burkitt's lymphoma and multiple myeloma by increasing the level of expression of p21(WAF-1), and transcription factors that bind to CpG-rich promoter regions are involved in this process.